Related Experiment Video

Updated: Aug 8, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.3K

Genome editing prevents hypertrophic cardiomyopathy in mice

Gregory B Lim1

  • 1Nature Reviews Cardiology, . nrcardio@nature.com.

Nature Reviews. Cardiology
|February 28, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.2K
Transverse Aortic Constriction in Mice
08:25

Transverse Aortic Constriction in Mice

Published on: April 21, 2010

67.4K

Related Experiment Videos

Last Updated: Aug 8, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.3K
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.2K
Transverse Aortic Constriction in Mice
08:25

Transverse Aortic Constriction in Mice

Published on: April 21, 2010

67.4K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

21
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

14.1K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.1K

Articles linked to this work by shared authors, journal, and citation graph.

Dyslipidaemia and hepatic steatosis: mechanisms and implications for lipid-lowering therapy.

Nature reviews. Cardiology·2026

Nicotine-containing products and the cardiovascular system: mechanisms and global health implications.

Nature reviews. Cardiology·2026

Cardiac fibroblast diversity in HFpEF: states, niches, interorgan drivers and targets.

Nature reviews. Cardiology·2026

Haemolytic injury and cardiovascular disease.

Nature reviews. Cardiology·2026

Cardioprotective properties of empagliflozin and other SGLT2 inhibitors.

Nature reviews. Cardiology·2026

The cardiac 4D nucleome: nuclear and chromatin dynamics across development, disease and ageing.

Nature reviews. Cardiology·2026

PUM1 Promotes HCC Cell Proliferation and Inhibits Mitochondria‑mediated Apoptosis, Accompanied by Activation of the PI3K-AKT Pathway.

Journal of hepatocellular carcinoma·2026

Breaking the antimicrobial resistance dilemma: marine natural products, a treasure trove for the development of new anti-Staphylococcus aureus drugs.

Marine life science & technology·2026

Optimizing plasma-derived small extracellular vesicle purification to enhance downstream applications.

iScience·2026

Optimizing nucleic acid delivery using PF14 peptide and lipid nanoparticle systems.

International journal of pharmaceutics: X·2026

N-Terminal polarity reversal of cysteine-terminated peptides: A strategy to develop potent metallo-β-lactamase inhibitors with in vivo efficacy.

European journal of medicinal chemistry·2026

Non-Oncology Biomarkers in Precision Medicine: A Narrative Review.

Therapeutic innovation & regulatory science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us